Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial [Phase 2]

View source ↗

Summary

A Phase 2 FRACTIONATE trial compares single-session stereotactic radiosurgery (SRS) with fractionated SRS (FSRS) for intact brain metastases and is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mayo Clinic | Conditions: Metastatic Malignant Neoplasm in the Brain, Metastatic Malignant Solid Neoplasm | Phase 2 | Status: RECRUITING